Voquezna Dosage
Generic name: vonoprazan fumarate 13.36mg
Dosage form: tablet
Drug class: Proton pump inhibitors
Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.
Recommended Dosage
Healing of Erosive Esophagitis
- The recommended adult oral dosage is VOQUEZNA 20 mg once daily for 8 weeks for the treatment of healing of erosive esophagitis and relief of associated heartburn.
Maintenance of Healed Erosive Esophagitis
- The recommended adult oral dosage is VOQUEZNA 10 mg once daily for up to 6 months for the maintenance of healed erosive esophagitis and relief of associated heartburn.
Relief of Heartburn Associated with Non-Erosive Gastroesophageal Reflux Disease
- The recommended adult oral dosage is VOQUEZNA 10 mg once daily for 4 weeks.
Treatment of H. pylori Infection
- Triple Therapy: The recommended adult oral dosage is VOQUEZNA 20 mg plus amoxicillin 1,000 mg plus clarithromycin 500 mg, each given twice daily (in the morning and evening, 12 hours apart) for 14 days.
- Dual Therapy: The recommended adult oral dose is VOQUEZNA 20 mg given twice daily (in the morning and evening) plus amoxicillin 1,000 mg three times daily (in the morning, mid-day, and evening) for 14 days.
- Also refer to the amoxicillin and clarithromycin full prescribing information.
Recommended Dosage in Patients with Renal Impairment
Healing of Erosive Esophagitis
The recommended dosage of VOQUEZNA in adult patients with renal impairment is described in Table 1 below.
Estimated glomerular filtration rate (GFR) | Recommended Dosage |
---|---|
30 mL/minute or greater | 20 mg once daily |
Less than 30 mL/minute | 10 mg once daily |
Maintenance of Healed Erosive Esophagitis or Relief of Heartburn Associated with Non-Erosive Gastroesophageal Reflux Disease
The recommended dosage of VOQUEZNA in adult patients with renal impairment is the same as for adult patients with normal renal function.
Treatment of H. pylori Infection
The recommended dosage of VOQUEZNA in adult patients with renal impairment is described in Table 2 below.
Estimated GFR | Recommended Dosage |
---|---|
|
|
30 mL/minute or greater | 20 mg twice daily |
Less than 30 mL/minute | Use is not recommended |
Recommended Dosage in Patients with Hepatic Impairment
Healing of Erosive Esophagitis
The recommended dosage of VOQUEZNA in adult patients with hepatic impairment is described in Table 3 below.
Classification | Recommended Dosage |
---|---|
Child-Pugh Class A | 20 mg once daily |
Child-Pugh Class B | 10 mg once daily |
Child-Pugh Class C | 10 mg once daily |
Maintenance of Healed Erosive Esophagitis or Relief of Heartburn Associated with Non-Erosive Gastroesophageal Reflux Disease
The recommended dosage of VOQUEZNA in adult patients with hepatic impairment is the same as for patients with normal hepatic function.
Treatment of H. pylori Infection
The recommended dosage of VOQUEZNA in adult patients with hepatic impairment is described in Table 4 below.
Classification | Recommended Dosage |
---|---|
Child-Pugh Class A | 20 mg twice daily |
Child-Pugh Class B | Use is not recommended |
Child-Pugh Class C | Use is not recommended |
Administration Instructions
- Take VOQUEZNA with or without food.
- Swallow VOQUEZNA tablets whole; do not chew or crush the tablet.
- Missed doses:
- For the healing or maintenance of healed erosive esophagitis, or the relief of heartburn associated with non-erosive gastroesophageal reflux disease: If a dose is missed, administer VOQUEZNA as soon as possible within 12 hours after the missed dose. If more than 12 hours have passed, skip the missed dose and administer the next dose at the regularly scheduled time.
- For the treatment of H. pylori infection: If a dose is missed, administer VOQUEZNA as soon as possible within 4 hours after the missed dose. If more than 4 hours have passed, skip the missed dose and administer the next dose at the regularly scheduled time. Continue the normal dosing schedule until the treatment is completed.
More about Voquezna (vonoprazan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: proton pump inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.